{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:59:28Z","timestamp":1772233168714,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"China Zhongguancun Precision Medicine Science And Technology Foundation","award":["GYLZH50"],"award-info":[{"award-number":["GYLZH50"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02531-6","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T04:23:44Z","timestamp":1736396624000},"page":"1121-1136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long noncoding RNA FAM111A-DT promotes aggressiveness of papillary thyroid cancer via activating NF-\u03baB signaling"],"prefix":"10.1007","volume":"48","author":[{"given":"Junxin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijun","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haipeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1818-5467","authenticated-orcid":false,"given":"Hongyu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"issue":"5","key":"2531_CR1","first-page":"425","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME (2024) Thyroid Cancer: Rev JAMA 331(5):425\u2013435","journal-title":"Thyroid Cancer: Rev JAMA"},{"issue":"4","key":"2531_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, Vaccarella S (2022) The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol 10(4):264\u2013272","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2531_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2531_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simoes M, Tallini G et al (2022) Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol 33(1):27\u201363","journal-title":"Endocr Pathol"},{"issue":"3","key":"2531_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.14639\/0392-100X-N1412","volume":"41","author":"A Ywata de Carvalho","year":"2021","unstructured":"Ywata de Carvalho A, Kohler HF, Gomes CC, Vartanian JG, Kowalski LP (2021) Predictive factors for recurrence of papillary thyroid carcinoma: analysis of 4,085 patients. Acta Otorhinolaryngol Ital 41(3):236\u2013242","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"7","key":"2531_CR6","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1007\/s12325-020-01391-1","volume":"37","author":"A Coca-Pelaz","year":"2020","unstructured":"Coca-Pelaz A, Shah JP, Hernandez-Prera JC, Ghossein RA, Rodrigo JP, Hartl DM, Olsen KD, Shaha AR, Zafereo M, Suarez C et al (2020) Papillary thyroid Cancer-aggressive variants and impact on management: a narrative review. Adv Ther 37(7):3112\u20133128","journal-title":"Adv Ther"},{"issue":"3","key":"2531_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K, Bayraktar R, Ferracin M, Calin GA (2024) Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 25(3):211\u2013232","journal-title":"Nat Rev Genet"},{"key":"2531_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","volume":"75","author":"EM McCabe","year":"2021","unstructured":"McCabe EM, Rasmussen TP (2021) lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol 75:38\u201348","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"2531_CR9","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41576-024-00693-2","volume":"25","author":"M Coan","year":"2024","unstructured":"Coan M, Haefliger S, Ounzain S, Johnson R (2024) Targeting and engineering long non-coding RNAs for cancer therapy. Nat Rev Genet 25(8):578\u2013595","journal-title":"Nat Rev Genet"},{"issue":"10","key":"2531_CR10","doi-asserted-by":"publisher","first-page":"e1002949","DOI":"10.1371\/journal.ppat.1002949","volume":"8","author":"DA Fine","year":"2012","unstructured":"Fine DA, Rozenblatt-Rosen O, Padi M, Korkhin A, James RL, Adelmant G, Yoon R, Guo L, Berrios C, Zhang Y et al (2012) Identification of FAM111A as an SV40 host range restriction and adenovirus helper factor. PLoS Pathog 8(10):e1002949","journal-title":"PLoS Pathog"},{"issue":"6","key":"2531_CR11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.ajhg.2013.04.020","volume":"92","author":"S Unger","year":"2013","unstructured":"Unger S, Gorna MW, Le Bechec A, Do Vale-Pereira S, Bedeschi MF, Geiberger S, Grigelioniene G, Horemuzova E, Lalatta F, Lausch E et al (2013) FAM111A mutations result in hypoparathyroidism and impaired skeletal development. Am J Hum Genet 92(6):990\u2013995","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2531_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H (2020) Targeting NF-kappaB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther 5(1):209","journal-title":"Signal Transduct Target Ther"},{"key":"2531_CR13","doi-asserted-by":"crossref","unstructured":"Betzler AC, Theodoraki MN, Schuler PJ, Doscher J, Laban S, Hoffmann TK, Brunner C (2020) NF-kappaB and its role in Checkpoint Control. Int J Mol Sci 21(11)","DOI":"10.3390\/ijms21113949"},{"issue":"8","key":"2531_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.trecan.2020.04.003","volume":"6","author":"B Eluard","year":"2020","unstructured":"Eluard B, Thieblemont C, Baud V (2020) NF-kappaB in the New Era of Cancer Therapy. Trends Cancer 6(8):677\u2013687","journal-title":"Trends Cancer"},{"issue":"7","key":"2531_CR15","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1002\/jcp.30759","volume":"237","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V (2022) NF-kappaB as a regulator of cancer metastasis and therapy response: a focus on epithelial-mesenchymal transition. J Cell Physiol 237(7):2770\u20132795","journal-title":"J Cell Physiol"},{"issue":"1","key":"2531_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12964-023-01207-z","volume":"21","author":"A Oh","year":"2023","unstructured":"Oh A, Pardo M, Rodriguez A, Yu C, Nguyen L, Liang O, Chorzalska A, Dubielecka PM (2023) NF-kappaB signaling in neoplastic transition from epithelial to mesenchymal phenotype. Cell Commun Signal 21(1):291","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2531_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2009.10.010","volume":"321","author":"F Pacifico","year":"2010","unstructured":"Pacifico F, Leonardi A (2010) Role of NF-kappaB in thyroid cancer. Mol Cell Endocrinol 321(1):29\u201335","journal-title":"Mol Cell Endocrinol"},{"key":"2531_CR18","doi-asserted-by":"crossref","unstructured":"Crescenzi E, Leonardi A, Pacifico F (2024) NF-kappaB in thyroid Cancer: an update. Int J Mol Sci 25(21)","DOI":"10.3390\/ijms252111464"},{"issue":"12","key":"2531_CR19","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1210\/en.2006-0400","volume":"147","author":"I Palona","year":"2006","unstructured":"Palona I, Namba H, Mitsutake N, Starenki D, Podtcheko A, Sedliarou I, Ohtsuru A, Saenko V, Nagayama Y, Umezawa K et al (2006) BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation. Endocrinology 147(12):5699\u20135707","journal-title":"Endocrinology"},{"issue":"2","key":"2531_CR20","doi-asserted-by":"publisher","first-page":"e0172689","DOI":"10.1371\/journal.pone.0172689","volume":"12","author":"M Faria","year":"2017","unstructured":"Faria M, Matos P, Pereira T, Cabrera R, Cardoso BA, Bugalho MJ, Silva AL (2017) RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells. PLoS ONE 12(2):e0172689","journal-title":"PLoS ONE"},{"issue":"3","key":"2531_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159(3):676\u2013690","journal-title":"Cell"},{"issue":"1","key":"2531_CR22","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1080\/07853890.2023.2192049","volume":"55","author":"Y Su","year":"2023","unstructured":"Su Y, Xu B, Li J, Shen Q, Lei Z, Ma M, Zhang F, Hu T (2023) Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer. Ann Med 55(1):1298\u20131316","journal-title":"Ann Med"},{"issue":"3","key":"2531_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.31083\/j.fbl2703101","volume":"27","author":"KS Lee","year":"2022","unstructured":"Lee KS, Park H (2022) Machine learning on thyroid disease: a review. Front Biosci (Landmark Ed) 27(3):101","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"9","key":"2531_CR24","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1111\/jcmm.14386","volume":"23","author":"F Guo","year":"2019","unstructured":"Guo F, Fu Q, Wang Y, Sui G (2019) Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p\/CCND1 axis. J Cell Mol Med 23(9):5907\u20135919","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2531_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV et al (2018) An Integrated TCGA Pan-cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell 173(2):400\u2013416 e411","journal-title":"Cell"},{"issue":"21","key":"2531_CR26","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252\u20137259","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2531_CR27","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1093\/nar\/gkt006","volume":"41","author":"L Wang","year":"2013","unstructured":"Wang L, Park HJ, Dasari S, Wang S, Kocher JP, Li W (2013) CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res 41(6):e74","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"2531_CR28","doi-asserted-by":"publisher","first-page":"W12","DOI":"10.1093\/nar\/gkx428","volume":"45","author":"YJ Kang","year":"2017","unstructured":"Kang YJ, Yang DC, Kong L, Hou M, Meng YQ, Wei L, Gao G (2017) CPC2: a fast and accurate coding potential calculator based on sequence intrinsic features. Nucleic Acids Res 45(W1):W12\u2013W16","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"2531_CR29","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and Cancer: a New Paradigm. Cancer Res 77(15):3965\u20133981","journal-title":"Cancer Res"},{"issue":"9","key":"2531_CR30","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1111\/cas.15886","volume":"114","author":"J Pu","year":"2023","unstructured":"Pu J, Xu Z, Huang Y, Nian J, Yang M, Fang Q, Wei Q, Huang Z, Liu G, Wang J et al (2023) N(6) -methyladenosine-modified FAM111A-DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A. Cancer Sci 114(9):3649\u20133665","journal-title":"Cancer Sci"},{"key":"2531_CR31","doi-asserted-by":"publisher","first-page":"9752","DOI":"10.12659\/MSM.917845","volume":"25","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Jin T, Shen H, Yan J, Guan M, Jin X (2019) Identification of long non-coding RNA expression profiles and co-expression genes in thyroid carcinoma based on the Cancer Genome Atlas (TCGA) database. Med Sci Monit 25:9752\u20139769","journal-title":"Med Sci Monit"},{"issue":"2","key":"2531_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"YT Tan","year":"2021","unstructured":"Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ (2021) LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond) 41(2):109\u2013120","journal-title":"Cancer Commun (Lond)"},{"issue":"6","key":"2531_CR33","doi-asserted-by":"publisher","first-page":"9105","DOI":"10.1002\/jcp.27587","volume":"234","author":"X Kong","year":"2019","unstructured":"Kong X, Duan Y, Sang Y, Li Y, Zhang H, Liang Y, Liu Y, Zhang N, Yang Q (2019) LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol 234(6):9105\u20139117","journal-title":"J Cell Physiol"},{"issue":"1","key":"2531_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13046-023-02847-2","volume":"42","author":"F Wang","year":"2023","unstructured":"Wang F, Hu Y, Wang H, Hu P, Xiong H, Zeng Z, Han S, Wang D, Wang J, Zhao Y et al (2023) LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2. J Exp Clin Cancer Res 42(1):267","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"2531_CR35","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s41418-023-01157-6","volume":"30","author":"L Shi","year":"2023","unstructured":"Shi L, Duan R, Sun Z, Jia Q, Wu W, Wang F, Liu J, Zhang H, Xue X (2023) LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer. Cell Death Differ 30(6):1517\u20131532","journal-title":"Cell Death Differ"},{"issue":"1","key":"2531_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3109\/10799893.2016.1171341","volume":"37","author":"F Wang","year":"2017","unstructured":"Wang F, Liu Y, Bi Z (2017) Pioglitazone inhibits growth of human retinoblastoma cells via regulation of NF-kappaB inflammation signals. J Recept Signal Transduct Res 37(1):94\u201399","journal-title":"J Recept Signal Transduct Res"},{"key":"2531_CR37","doi-asserted-by":"publisher","first-page":"109790","DOI":"10.1016\/j.biopha.2019.109790","volume":"123","author":"H Cai","year":"2020","unstructured":"Cai H, Yan L, Liu N, Xu M, Cai H (2020) IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway. Biomed Pharmacother 123:109790","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2531_CR38","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1080\/21691401.2019.1664559","volume":"47","author":"T Yi","year":"2019","unstructured":"Yi T, Zhou X, Sang K, Huang X, Zhou J, Ge L (2019) Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway. Artif Cells Nanomed Biotechnol 47(1):3765\u20133773","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"8","key":"2531_CR39","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","volume":"20","author":"RI Haddad","year":"2022","unstructured":"Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H et al (2022) Thyroid carcinoma, Version 2.2022, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw 20(8):925\u2013951","journal-title":"J Natl Compr Canc Netw"},{"key":"2531_CR40","doi-asserted-by":"publisher","first-page":"151973","DOI":"10.1016\/j.anndiagpath.2022.151973","volume":"59","author":"P Celepli","year":"2022","unstructured":"Celepli P, Bigat I, Karabulut S, Celepli S, Hucumenoglu S (2022) Evaluation of Lipocalin-2 and twist expression in thyroid cancers and its relationship with epithelial mesenchymal transition. Ann Diagn Pathol 59:151973","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"2531_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/ERC-17-0182","volume":"25","author":"K Tsumagari","year":"2018","unstructured":"Tsumagari K, Abd Elmageed ZY, Sholl AB, Green EA, Sobti S, Khan AR, Kandil A, Murad F, Friedlander P, Boulares AH et al (2018) Bortezomib sensitizes thyroid cancer to BRAF inhibitor in vitro and in vivo. Endocr Relat Cancer 25(1):99\u2013109","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"2531_CR42","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00432-017-2380-z","volume":"143","author":"S Schwertheim","year":"2017","unstructured":"Schwertheim S, Wein F, Lennartz K, Worm K, Schmid KW, Sheu-Grabellus SY (2017) Curcumin induces G2\/M arrest, apoptosis, NF-kappaB inhibition, and expression of differentiation genes in thyroid carcinoma cells. J Cancer Res Clin Oncol 143(7):1143\u20131154","journal-title":"J Cancer Res Clin Oncol"},{"issue":"20","key":"2531_CR43","doi-asserted-by":"publisher","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-04-0463","volume":"10","author":"DV Starenki","year":"2004","unstructured":"Starenki DV, Namba H, Saenko VA, Ohtsuru A, Maeda S, Umezawa K, Yamashita S (2004) Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin. Clin Cancer Res 10(20):6821\u20136829","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2531_CR44","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA (2021) Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov 20(8):629\u2013651","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"2531_CR45","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd4140","volume":"12","author":"H Ling","year":"2013","unstructured":"Ling H, Fabbri M, Calin GA (2013) MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 12(11):847\u2013865","journal-title":"Nat Rev Drug Discov"}],"updated-by":[{"DOI":"10.1007\/s40618-025-02538-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000}}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02531-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02531-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02531-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T07:02:18Z","timestamp":1746255738000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02531-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2531"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02531-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40618-025-02538-z","asserted-by":"object"}]},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: due to one of the author's name was mistakenly listed in the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40618-025-02538-z","URL":"https:\/\/doi.org\/10.1007\/s40618-025-02538-z","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the Institutional Research Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University. The samples were obtained with informed consent from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}